COM:GRIBIO
GRI Bio, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalwebsite
gribio.com/crunchbase
gri-biolinkedin
glycoregimmune-inc.founding date
Jan 01, 2009
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, retur...Show More